Healthcare · Drug Manufacturers General · NYSE
| Market cap | $1.04T |
|---|---|
| Trailing P/E | 37.2 |
| FCF yield | 0.6% |
| Revenue growth (YoY) | +44.7% |
| EPS growth (YoY) | +86.2% |
| FCF/share growth (YoY) | +1348.2% |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
Eli Lilly and Company trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| John Boozman | Senate | Sell | $1,001 - $15,000 | Aug 24, 2026 |
| Michael Rulli | House | Sell | $1,001 - $15,000 | Aug 7, 2026 |
| Michael Rulli | House | Buy | $1,001 - $15,000 | Aug 7, 2026 |
| Michael Rulli | House | Sell | $1,001 - $15,000 | Aug 7, 2026 |
| Thomas H Tuberville | Senate | Sell | $15,001 - $50,000 | Aug 5, 2026 |
| Thomas H Tuberville | Senate | Sell | $15,001 - $50,000 | Aug 5, 2026 |
| Alan Armstrong | Senate | Sell | $1,001 - $15,000 | Jul 21, 2026 |
| Alan Armstrong | Senate | Sell | $1,001 - $15,000 | Jul 21, 2026 |
| Dan Newhouse | House | Sell | $1,001 - $15,000 | Jul 17, 2026 |
| Gilbert Cisneros | House | Buy | $50,001 - $100,000 | Jul 2, 2026 |
| Byron Donalds | House | Buy | $1,001 - $15,000 | May 13, 2026 |
| Byron Donalds | House | Buy | $1,001 - $15,000 | May 13, 2026 |